Addison’s Disease Market to grow at a CAGR of 10.4% till 2023: Global Analysis by Major Key Drivers like Pfizer Inc.,Boehringer Ingelheim International GmbH,Shire,Tocris Bioscience,GlaxoSmithKline Plc,Merck KGaA,Lupin Pharmaceuticals, Inc.,etc.

Global Addison's Disease Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 168 million in 2017 and is projected to grow at a CAGR of 10.4% over the forecast period.

Addison's disease is a disorder which occurs when the body produces scarce amounts of specific hormones produced by the adrenal glands. When a person has Addison's disease, the adrenal glands produce too little cortisol and often inadequate levels of aldosterone as well. It is also known as adrenal insufficiency. Addison's disease can affect all age groups and can occur in both males & females. The disease can be life-threatening.

Global Addison’s Disease Market, by Key Players

Pfizer Inc.
Boehringer Ingelheim International GmbH
Shire
Tocris Bioscience
GlaxoSmithKline Plc
Merck KGaA
Lupin Pharmaceuticals, Inc.
Abbott
Amgen Limited & Amgen Ireland Limited

Inquire for Sample Copy of this Report https://www.marketresearchfuture.com/sample_request/6628

Major Factors such as the growing prevalence of Addison’s disease, increasing awareness of the disease, and rising healthcare expenditure is expected to propel the growth of the market. However, lack of awareness and inability to diagnose the disease in early stages can hamper the market growth over the forecast period.

Global Addison’s Disease Market has been segmented into diagnosis, treatment and end user.

The market, on the basis of diagnosis, has been segmented into laboratory tests and imaging tests. Laboratory tests have been further segmented into blood tests, ACTH stimulation tests, insulin-induced hypoglycemia test, and other tests.

Blood tests are expected to hold the largest market share owing to their high effectiveness to diagnose the disease and preference among the physicians.
ACTH stimulation test is expected to be the fastest growing market due to the low cost of the diagnosis method.
Imaging tests have been segmented into chest radiography and CT scan.
The market, by treatment, has been segmented into oral corticosteroids and corticosteroids injections.

The market, by end user, has been segmented into hospitals & clinics, diagnostic laboratories, and other end users.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Addison’s Disease Market, By Diagnosis

Chapter 7. Global Addison’s Disease Market, By Treatment

Chapter 8. Global Addison’s Disease Market, By End User

Chapter 9. Global Addison’s Disease Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12. MRFR Conclusion

Chapter 13. Appendix

LIST OF TABLES

LIST OF FIGURES

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/addison-s-disease-market-6628

Geographically, the Americas is anticipated to dominate the global Addison's disease market owing to a well-developed healthcare sector and the rising prevalence of the disease. According to a report published by the Centers Medicare and Medicaid Services in April 2018, National Healthcare Expenditure grew by 4.3% to USD 3.3 trillion in 2016 from the previous year.

Europe is expected to hold the second largest position in the global Addison’s disease market. The market growth in this region is attributed to the increasing number of Addison’s disease cases and the developed healthcare infrastructure. According to the World Health Organization, Germany spent USD 5182 per capita on healthcare.

The Addison’s disease market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the increasing prevalence of Addison’s disease and growing awareness of the same. According to the World Bank Group, India spent 3.89% of its GDP on health in 2015.

The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.

Get Exclusive discount on https://www.marketresearchfuture.com/check-discount/6628

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.